Complementary and Integrative Medicine for the Treatment of Trigeminal Neuralgia and Trigeminal Autonomic Cephalalgia.
Autor: | Kuruvilla DE; Westport Headache Institute, 1 Turkey Hill Road South, Suite 201, Westport, CT, USA, 06880. Deenakuruvilla@gmail.com., Natbony L; Integrative Headache Medicine of New York, New York, NY, 10016, USA., Chandwani B; Tufts University, Boston, MA, USA., Jann A; NYU Langone Health, New York, NY, USA., Bradley BA; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA., Zhang N; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Palo Alto, CA, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Current pain and headache reports [Curr Pain Headache Rep] 2024 Apr; Vol. 28 (4), pp. 195-203. Date of Electronic Publication: 2024 Jan 29. |
DOI: | 10.1007/s11916-024-01212-y |
Abstrakt: | Purpose of Review: Trigeminal neuralgia (TN) and trigeminal autonomic cephalalgias (TACs) are both painful diseases which directly impact the branches of the trigeminal nerve, which supply the face. Patients who have experienced adverse effects, have not responded to mainstream treatments, or have a personal preference for nonmedication options, often turn to complementary and integrative medicine (CIM). The aim of this review is to discuss the efficacy and safety of CIM therapies available for the treatment of TN and TACs. Recent Findings: Not only are there limited therapeutic options for TN and TAC patients, but also is there a proportion of patients who are intolerant to standard medical treatments. Recent findings have illustrated that 86% of patients with headache disorders utilize CIM modalities in combination with mainstream medical therapy. CIM modalities can be helpful for these diseases and have primarily been studied in combination with standard medical therapy. There is limited evidence for CIM and behavioral therapies in managing these conditions, and more research is needed to confirm which therapies are safe and effective. (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.) |
Databáze: | MEDLINE |
Externí odkaz: |